Literature DB >> 31563398

Cemented Proximal Femoral Replacement for the Management of Non-Neoplastic Conditions: A Versatile Implant but Not Without Its Risks.

Christopher Fenelon1, Evelyn P Murphy1, Stephen R Kearns1, William Curtin1, Colin G Murphy1.   

Abstract

BACKGROUND: The demand for revision arthroplasty continues to grow. Proximal femoral bone loss poses a significant challenge to surgeons and proximal femoral replacements (PFRs) are one option to address this problem. The aim of our study is to assess the reoperation, complication, and mortality rates following PFR for treatment of non-neoplastic conditions.
METHODS: A retrospective observational study was conducted of a consecutive group of patients treated with a PFR for non-neoplastic conditions between 2010 and 2018. Mortality was confirmed using the Irish national death events publication service.
RESULTS: Over the 8-year study period, 79 PFRs in 78 patients were performed. Mean age of patients was 78.3 years (standard deviation 11.9), of which 37.2% were male. Periprosthetic fracture was the most common indication for PFR (63.3%). The 30-day mortality rate was 7.6% (6 patients), of which bone cement implantation syndrome occurred in 4 patients. One-year mortality was 12.7%. Complications occurred in 22.8%.
CONCLUSION: A cemented PFR is a versatile prosthesis in the armamentarium of a revision arthroplasty surgeon that allows immediate full weight-bearing. However, it may appropriately be considered a last resort procedure that poses specific risks that must be explained to patients and family. We present the short-term outcomes on one of the largest series of PFR to date.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  mortality; non-neoplastic; periprosthetic; proximal femoral replacement; revision

Year:  2019        PMID: 31563398     DOI: 10.1016/j.arth.2019.09.010

Source DB:  PubMed          Journal:  J Arthroplasty        ISSN: 0883-5403            Impact factor:   4.757


  3 in total

1.  Survivorship and clinical outcomes of proximal femoral replacement in non-neoplastic primary and revision total hip arthroplasty: a systematic review.

Authors:  Fabio Mancino; Vincenzo Di Matteo; Fabrizio Mocini; Giorgio Cacciola; Giuseppe Malerba; Carlo Perisano; Ivan De Martino
Journal:  BMC Musculoskelet Disord       Date:  2021-11-08       Impact factor: 2.562

2.  Proximal femoral replacement for non-neoplastic conditions: a systematic review on current outcomes.

Authors:  Alberto Di Martino; Davide Pederiva; Barbara Bordini; Gabriele Di Carlo; Alessandro Panciera; Giuseppe Geraci; Niccolò Stefanini; Cesare Faldini
Journal:  J Orthop Traumatol       Date:  2022-03-29

3.  Proximal femoral reconstruction with modular megaprostheses in non-oncological patients.

Authors:  Kevin Döring; Klemens Vertesich; Luca Martelanz; Kevin Staats; Christoph Böhler; Christian Hipfl; Reinhard Windhager; Stephan Puchner
Journal:  Int Orthop       Date:  2021-07-14       Impact factor: 3.075

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.